A detailed history of Us Bancorp \De\ transactions in Amgen Inc stock. As of the latest transaction made, Us Bancorp \De\ holds 738,025 shares of AMGN stock, worth $217 Million. This represents 0.25% of its overall portfolio holdings.

Number of Shares
738,025
Previous 751,095 1.74%
Holding current value
$217 Million
Previous $242 Million 20.52%
% of portfolio
0.25%
Previous 0.31%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 05, 2025

SELL
$258.78 - $328.31 $3.38 Million - $4.29 Million
-13,070 Reduced 1.74%
738,025 $192 Million
Q3 2024

Oct 28, 2024

SELL
$309.38 - $337.38 $2.36 Million - $2.58 Million
-7,639 Reduced 1.01%
751,095 $242 Million
Q2 2024

Aug 06, 2024

BUY
$262.75 - $319.31 $3.18 Million - $3.86 Million
12,103 Added 1.62%
758,734 $237 Million
Q1 2024

May 07, 2024

BUY
$268.87 - $324.56 $877,591 - $1.06 Million
3,264 Added 0.44%
746,631 $212 Million
Q4 2023

Feb 09, 2024

SELL
$255.7 - $288.46 $10.3 Million - $11.6 Million
-40,361 Reduced 5.15%
743,367 $214 Million
Q3 2023

Nov 03, 2023

BUY
$218.65 - $271.46 $3.35 Million - $4.16 Million
15,330 Added 2.0%
783,728 $211 Million
Q2 2023

Aug 09, 2023

SELL
$214.27 - $253.37 $3.83 Million - $4.53 Million
-17,863 Reduced 2.27%
768,398 $171 Million
Q1 2023

May 09, 2023

SELL
$225.79 - $275.2 $2.03 Million - $2.47 Million
-8,973 Reduced 1.13%
786,261 $190 Million
Q4 2022

Feb 13, 2023

BUY
$229.03 - $291.01 $23.1 Million - $29.4 Million
101,070 Added 14.56%
795,234 $209 Million
Q3 2022

Oct 27, 2022

SELL
$224.46 - $253.15 $1.55 Million - $1.74 Million
-6,893 Reduced 0.98%
694,164 $156 Million
Q2 2022

Aug 01, 2022

SELL
$230.71 - $256.74 $1.27 Million - $1.42 Million
-5,518 Reduced 0.78%
701,057 $171 Million
Q1 2022

May 11, 2022

BUY
$219.27 - $242.57 $2.93 Million - $3.25 Million
13,382 Added 1.93%
706,575 $171 Million
Q4 2021

Feb 11, 2022

BUY
$198.88 - $227.6 $907,091 - $1.04 Million
4,561 Added 0.66%
693,193 $156 Million
Q3 2021

Nov 10, 2021

BUY
$212.27 - $248.7 $2.2 Million - $2.58 Million
10,372 Added 1.53%
688,632 $146 Million
Q2 2021

Aug 05, 2021

SELL
$233.58 - $259.14 $1.03 Million - $1.15 Million
-4,424 Reduced 0.65%
678,260 $165 Million
Q1 2021

Apr 28, 2021

SELL
$221.91 - $258.6 $6.9 Million - $8.04 Million
-31,107 Reduced 4.36%
682,684 $170 Million
Q4 2020

Feb 04, 2021

BUY
$216.38 - $257.67 $8.27 Million - $9.84 Million
38,207 Added 5.66%
713,791 $164 Million
Q3 2020

Nov 10, 2020

BUY
$234.65 - $260.95 $1.6 Million - $1.77 Million
6,800 Added 1.02%
675,584 $172 Million
Q2 2020

Aug 07, 2020

SELL
$197.81 - $242.74 $143,016 - $175,501
-723 Reduced 0.11%
668,784 $158 Million
Q1 2020

May 13, 2020

SELL
$182.24 - $241.7 $901,359 - $1.2 Million
-4,946 Reduced 0.73%
669,507 $136 Million
Q4 2019

Feb 04, 2020

SELL
$189.21 - $243.2 $5.33 Million - $6.85 Million
-28,165 Reduced 4.01%
674,453 $163 Million
Q3 2019

Nov 08, 2019

BUY
$174.11 - $208.62 $5.59 Million - $6.69 Million
32,083 Added 4.78%
702,618 $136 Million
Q2 2019

Aug 13, 2019

BUY
$166.7 - $195.41 $4.78 Million - $5.6 Million
28,661 Added 4.47%
670,535 $124 Million
Q1 2019

May 08, 2019

SELL
$180.87 - $203.88 $2.61 Million - $2.94 Million
-14,439 Reduced 2.2%
641,874 $122 Million
Q4 2018

Feb 13, 2019

SELL
$178.4 - $208.25 $641,526 - $748,867
-3,596 Reduced 0.54%
656,313 $128 Million
Q3 2018

Nov 01, 2018

SELL
$185.29 - $208.89 $2.07 Million - $2.34 Million
-11,180 Reduced 1.67%
659,909 $137 Million
Q2 2018

Aug 08, 2018

SELL
$166.05 - $186.51 $1.36 Million - $1.52 Million
-8,169 Reduced 1.2%
671,089 $124 Million
Q1 2018

May 08, 2018

SELL
$169.43 - $198.0 $3.83 Million - $4.48 Million
-22,616 Reduced 3.22%
679,258 $116 Million
Q4 2017

Feb 02, 2018

SELL
$168.79 - $188.59 $774,239 - $865,062
-4,587 Reduced 0.65%
701,874 $122 Million
Q3 2017

Nov 13, 2017

BUY
$167.29 - $191.0 $118 Million - $135 Million
706,461
706,461 $132 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $157B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Us Bancorp \De\ Portfolio

Follow Us Bancorp \De\ and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Us Bancorp \De\, based on Form 13F filings with the SEC.

News

Stay updated on Us Bancorp \De\ with notifications on news.